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Abstract
Myopia is one of the most common ocular disorders worldwide. Pathological myopia, also called high myopia, comprises
1% to 5% of the general population and is one of the leading causes of legal blindness in developed countries. To identify
genetic determinants associated with pathological myopia in Japanese, we conducted a genome-wide association study,
analyzing 411,777 SNPs with 830 cases and 1,911 general population controls in a two-stage design (297 cases and 934
controls in the first stage and 533 cases and 977 controls in the second stage). We selected 22 SNPs that showed P-values
smaller than 10
24 in the first stage and tested them for association in the second stage. The meta-analysis combining the
first and second stages identified an SNP, rs577948, at chromosome 11q24.1, which was associated with the disease
(P=2.22610
27 and OR of 1.37 with 95% confidence interval: 1.21–1.54). Two genes, BLID and LOC399959, were identified
within a 200-kb DNA encompassing rs577948. RT–PCR analysis demonstrated that both genes were expressed in human
retinal tissue. Our results strongly suggest that the region at 11q24.1 is a novel susceptibility locus for pathological myopia
in Japanese.
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Introduction
Myopia is a refractive error (http://en.wikipedia.org/wiki/
Refractive_error) of the eye in which parallel rays of light focus in
a plane anterior to the retina resulting in blurred vision. Myopia is
one of the most common ocular disorders worldwide, and is in
much higher prevalence in Asians than in Caucasians. Recent
population-based surveys in the elderly reported that the
prevalence of myopia was approximately 25% in the Caucasian
populations [1] and 40% in the East Asian (Chinese and Japanese)
populations [2,3].
Myopia is divided into two distinct subsets, namely, common
and pathological myopia. Pathological myopia, also called high
myopia, is distinguished from common myopia, also called low/
moderate myopia, by excessive increase in axial length of the
eyeball, which is the most important contributor to the myopic
refraction [4,5]. The axial length of the eyeball in adults is
approximately 24 mm, and its elongation by 1 mm without other
compensatory changes results in a myopic shift of 22.5 to 23.0
diopters (D). It has been shown that distribution of the axial
lengths of the adult myopic population is bimodal [6], and the
subgroup with elongated axial length in the bimodal distribution
corresponds to pathological myopia. This group comprises 1% to
5% of the population [3,7], and is commonly defined by axial
length greater than 26.0 mm which is equivalent to refractive
errors greater than 26 D [8].
The excessive elongation of the eyeball causes mechanical strain
with subsequent degenerative changes of the retina, choroid, and
sclera. The degenerative changes at the posterior pole of the eye
such as chorioretinal atrophy or posterior staphyloma are clinically
important and unique to pathological myopia [9]. These unique
degenerative changes at the posterior pole result in uncorrectable
visual impairment due to decreased central vision and make
pathological myopia one of the leading causes of legal blindness in
developed countries [10–13].
It has been reported that not only environmental factors, such
as near work and higher education, but also genetic factors
contribute to the development of myopia, in particular, of
pathological myopia [14]. Previous twin studies reported that the
estimated heritability of refractive error and axial length is up to
0.90 [15,16], although that might be overestimated due to
common environmental effects [17]. Multiple family-based whole
genome linkage analyses of myopia reported at least 16 susceptible
chromosomal loci (MYP1–16 in OMIM database; 10 loci for
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Among them, at least 8 chromosomal loci, such as 12q21–23
(MYP3), 22q12 (MYP6) and 2q37.1 (MYP12) were successfully
validated by at least two independent studies [31,32]. However, no
genes responsible for the disease have been identified.
The genome-wide association (GWA) study using single
nucleotide polymorphisms (SNPs) as markers is an alternative
approach to identify genetic risk factors of common diseases. This
approach has been successfully applied to identify genetic risk
factors for multigenetic diseases including ophthalmic diseases
such as age-related macular degeneration [33,34] and exfoliation
syndrome [35]. To identify the genetic risk factors of pathological
myopia, we conducted a two-stage GWA-based case/control
association analysis using 411,777 markers with 830 Japanese
patients and 1,911 Japanese controls (297 cases and 934 controls
in the first stage, and 533 cases and 977 controls in the second
stage).
Results
Characterization of the patients with pathological
myopia
A total of 839 pathological myopic patients with axial length
greater than 26.0 mm in both eyes were enrolled in the current
study. In order to maximize the detection power, patients with
axial length greater than 28.0 mm in both eyes were enrolled in
the first stage of genome scan. No other clinical features were
accounted for the assignment of patients to either stage. 824 out of
839 patients (98.2%) had degenerative changes specific to
pathological myopia. Other features of cases and controls who
passed quality control procedures of genotyping results (see
Materials and Methods) were summarized in Table 1.
Genome-wide association analysis
For the first stage, we scanned the genome of 302 cases using the
Illumina HumanHap550 BeadChip, which launches 561,466
relatively frequent SNPs (minor allele frequency .0.05) distributed
across the human genome at an average interval of 6.5 kilobases
(kb). Five cases and 149,689 SNPs were excluded due to quality
control criteria (see details in Materials and Methods) and
genotyping results of 411,777 SNPs in autosomes for 297 cases
were used for the statistical analysis. They were compared with 934
controls from the JSNP database [36] for association with
phenotype using x
2 test for trend. Genomic Control (GC) method
[37] revealed only a slight inflation of the test statistics (GC
parameter l=1.068). We identified 29 SNPs in 22 chromosomal
regions with P-value adjusted by GC being smaller than 10
24
(Figure 1 and Table S1). Among them, seven SNPs at chromosome
8p12 were in strong linkage disequilibrium (LD) and likewise two
SNPs at chromosome 10q22.2 (pair-wise D9.0.95 and r
2.0.9).
Thus, we selected one representing SNP from each region and
tested 22 SNPs in the second stage.
Author Summary
Myopia is one of the most common ocular disorders with
elongation of axis of the eyeball. Pathological myopia or
high myopia, a subset of myopia which is characterized
with excessive axial elongation and degenerative changes
of the eye, is a leading cause of visual impairment. Since
genetic factors play significant roles in its development,
identification of genetic determinants is an urgent and
important issue. Although family-based linkage analyses
have isolated at least 16 susceptible chromosomal loci for
pathological or common myopia, no gene responsible for
the disease has been identified. We conducted the first
genome-wide case/control association study of patholog-
ical myopia in a two-stage design using 411,777 markers
with 830 Japanese patients and 1,911 Japanese controls.
We identified a region strongly suggestive for the disease
susceptibility at chromosome 11q24.1 containing BLID and
LOC399959. Their expression was confirmed in human
retina with RT–PCR. BLID encodes an inducer of apoptotic
cell death, and apoptosis is known to play an important
functional role in pathological myopia. We believe that our
study contributes to further dissect the molecular events
underlying the development and progression of patho-
logical myopia.
Table 1. Characteristics of the study population used in the study
a.
Cases/Controls Category Subcategory First stage Second stage
Cases: Patients with pathological myopia Number 297 533
Age (years) 58.8613.2 59.0614.3
Gender Male 93 171
Female 204 362
Axial length (mm) Right eyes 29.9761.36 29.0461.97
Left eyes 29.8461.37 28.9161.89
Refraction of the phakic eyes (Diopter)
b Right eyes 214.9464.04 212.4064.48
Left eyes 214.6463.98 212.0764.72
Controls: general Japanese population Number 934 977
Age (years) NA 48.3616.3
Gender Male NA 497
Female NA 480
The 6 sign is a standard deviation.
aThe study population after quality control procedures.
bFor the calculations of refraction, 177 eyes (29.8%) in the first stage and 303 eyes (28.4%) in the second stage that had undergone cataract surgery or corneal refractive
surgery were excluded.
doi:10.1371/journal.pgen.1000660.t001
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controls were genotyped by Taqman method. Among them, four
cases and three controls were excluded due to low call rates
(,90%). Genotyping success rates of the 22 SNP markers in the
remaining 1,510 samples were greater than 96.8%. The genotype
counts of the first and second stages were combined for meta-
analysis. One SNP, rs577948, showed a strongly suggestive
association (P=2.22610
27) (Table 2) in the meta-analysis whereas
the remaining 21 SNPs were not significant (P .10
25) (Table S1).
Evaluation of the region with rs577948
The SNP rs577948 which showed P=2.22610
27 by meta-
analysis with OR of 1.37 (95% confidence interval (CI): 1.21–1.54)
for the risk allele (nominal P=2.80610
25 and P=1.42610
23 in
the first and second stages, respectively) (Table 2) was located at
chromosome 11q24.1 (Figure 2A). Using the results of the first
stage, an LD block which extended a 55-kb region containing
rs577948 was generated. Six additional SNP markers within the
block were included in the genome scan chip (Figure 2B). Among
them, we selected three markers with adjusted P-value smaller
than 0.01 in the first stage for further genotyping by Taqman
method with DNAs used for the second stage. Weaker associations
than that of rs577948 were obtained for these three markers by
meta-analysis (Table 2). As shown in Figure 2B, two genes were
located in a 200-kb region containing rs577948. BLID is a cell
death inducer containing BH3-like motif [38], which is located
approximately 44-kb upstream of rs577948. The other gene,
LOC399959, is a hypothetical non-coding RNA [39] which
encompassed 114-kb DNA in the region, and rs577948 is located
in its second intron.
Expression of the BLID and LOC399959
BLID is known as a cell-death inducer expressed in cytoplasm,
in mitochondria at lower abundance, and in various human
cancer cells from different tissues [38]. LOC399959 was reported
as a hypothetical non-coding RNA with a relatively ubiquitous
expression pattern. We assessed the expression of the genes by RT-
PCR using cDNAs of human retina and brain and those of HeLa
cells as positive control. Expressions of both genes were detected in
human retinal tissue as well as in human brain and HeLa cells
(Figure 3).
Figure 1. Manhattan plot of the first stage results for
pathological myopia. Adjusted P-values obtained by the trend x
2
test for 411,777 SNPs on autosomes in 297 pathological myopic cases
and 934 general population controls are plotted in 2log10 scale
according to their chromosome location.
doi:10.1371/journal.pgen.1000660.g001
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Myopic refraction and axial length are reported to be a complex
trait under polygenic control in which contribution of each gene is
relatively small [40]. In the current study, two-stage GWA analysis
identified a region at chromosome 11q24.1, in which rs577948
showed strongly suggestive P=2.22610
27 with OR of 1.37 (95%
CI: 1.21–1.54) for the allele G.
Our GWA study identified only one strongly-suggestive locus.
This may principally be due to the sample size of our study not
being adequate. Recent genetic studies of complex traits with
higher prevalence enroll much larger number of samples. In
contrast, recruitment of patients with pathological myopia is
difficult due to its lower prevalence, particularly those with
degenerative changes (namely degenerative myopia). In order to
improve insufficient detection power, we assigned pathological
myopia patients with longer axis (greater than 28.0 mm) to the first
stage. This strategy might be the reason we were successful in
identifying the candidate region with relatively small number of
cases.
Insufficiency of detection power due to a limitation in sample
number may be a reason for difference between the findings of
preceding linkage studies and ours. OMIM database lists 10 MYP
regions (MYP1–5, 11–13, 15 and 16) for pathological myopia [18–27]
Figure 2. Results of genome scan at 11q24.1 locus containing the BLID and LOC399959 genes. (A) Adjusted P-values on 2log10 scale for
SNPs examined for their association by the trend x
2 test. (B) Structures, orientations and locations of the BLID and LOC399959 genes on NCBI
Reference Sequence Build 36.1, together with pair-wise LD estimates of the SNP markers located within a 200-kb region encompassing the rs577948
marker (red box). Three additional SNP markers (rs11218544, rs11218553, and rs10892819), that showed adjusted P-value,10
22 in the first stage, are
also indicated.
doi:10.1371/journal.pgen.1000660.g002
Figure 3. Expression of the BLID and LOC399959 genes in the
human retina. RT–PCR analyses of BLID and LOC399959 expression in
HeLa cells, the human Brain and the human retina. GAPDH was used as
an internal control for cDNA quantification.
doi:10.1371/journal.pgen.1000660.g003
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None of these 16 MYPs are on chromosome 11q. Stambolian and
colleagues reported heterogeneity LOD score of 1.24 at 11q23 in their
linkage study for common myopia in Ashkenazi Jewish descent, which
is the closest locus to our region reported to date [29]. Because the
linkage signal was not strong and the band 11q23 (chr11, position
110,000 kb to 120,700 kb in the NCBI database) is more than
800 kilobases apart from our LD block in 11q24.1 (chr11, position
121,535 kb to 121,590 kb), whether or not they overlap each other is
inconclusive. On the other hand, our study did not identify the
associated SNPs in any of MYPs.
Although the insufficiency of detection power may be a reason
for difference between our study and the linkage studies, there are
other possible reasons. In general, any difference in the study
designs could cause heterogeneous results. Firstly, there are two
definitions of pathological myopia based on two distinct criteria,
namely, the axial length and refractive error. In the current study,
we enrolled pathological myopic patients based on the axial length
(greater than 26.0 mm in both eyes), and not on the refractive
error commonly used in the previous studies (refractive errors
greater than 26 D). We focused on patients with vision-
threatening degenerative changes [9] and the axial length fits
better than refractive error for our purpose. The mean refraction
in our myopic patients was 213.1464.57 D (eyes that had
undergone cataract surgery or corneal refractive surgery were
excluded from this calculation) which indeed correspond to
pathological myopic group in the previous linkage studies. On
the other hand, it is not clear whether the patients enrolled in the
linkage studies fulfill our criteria because the distribution of axial
length and degenerative phenotypes in the cases are unknown.
The difference in definition of pathological myopia may result in
different susceptibility loci between studies.
Secondly, the methodology used is different between studies,
namely, linkage analysis and association analysis using linkage
disequilibrium mapping. The results of linkage and association
studies of complex genetic traits are often different. Family-based
linkage analysis is much more suitable for identifying rare genetic
variants with large effects whereas SNP-based GWA analysis is
more powerful in detection of relatively common variants with
smaller effects in complex diseases [41].
Finally, the difference can also be due to the ethnicities of the
samples enrolled. In the current study, all cases and controls were
Japanese. Only one genome-wide linkage study has previously
been published for pathological myopia in Japanese [42] and the
others were for non-Japanese populations.
It would be interesting and important to examine the
association of our locus in other ethnicities. Ethnic variations in
disease susceptibility genes have been reported in various genetic
traits including ophthalmological disorders. One such example is
an SNP in the complement factor H gene (rs1061170) which has a
large effect size with age-related macular degeneration in
Caucasians [33,43,44] but much smaller in East Asian populations
due to a remarkably lower risk allele frequency (,35% in
Caucasians and ,5% in East Asians) [45]. Another example is
exfoliation syndrome and LOXL1 where the risk allele of
rs1048661 is inverted between Icelandic (allele G) and Japanese
(allele T) populations [35,46]. Because of a large variation in
prevalence of myopia among ethnic groups, a future trans-ethnic
investigation of myopia risk genes will be important to dissect
genetic backgrounds underlying the etiology of myopia.
Although the susceptibility locus contains BLID and
LOC399959, it seems premature to discuss the involvement of
LOC399959 in myopia since it is a hypothetical non-coding gene.
BLID plays a proapoptotic role involving the BH3-like domain by
inducing a caspase-dependent mitochondrial cell death pathway
[38]. Indeed, several animal and pathological studies suggested the
functional role of apoptosis in pathological myopia [47,48].
Moreover, a recent genome-wide linkage study followed by a
fine-scale association mapping identified a myopia susceptibility
gene locus containing the PARL gene which inhibits the
mitochondrial pathway of apoptosis by interaction with OPA1
[49]. In this context, BLID seems functionally relevant with the
pathogenesis of pathological myopia. However, the true functional
origin of association in this region has yet to be determined by
further detailed investigation along with replication studies to
validate our findings.
Materials and Methods
Study subjects
All procedures used in this study conformed to the tenets of the
Declaration of Helsinki. The Institutional Review Board and the
Ethics Committee of each institution approved the protocols used.
All the participants were fully informed of the purpose and
procedures, and a written consent was obtained from each.
Japanese pathological myopic cases were recruited at the Center
for Macular Diseases of Kyoto University Hospital, the High
Myopia Clinic of Tokyo Medical and Dental University, and
Fukushima Medical University Hospital. All subjects underwent
comprehensive ophthalmologic examinations, including dilated
indirect and contact lens slit-lamp biomicroscopy, automatic
objective refraction evaluation, and measurement of the axial
length by applanation A-scan ultrasonography (UD-6000, Tomey,
Nagoya, Japan) or partial coherence interferometry (IOLMaster,
Carl Zeiss Meditec, Dublin, CA).
As a general population control of the first stage, genotype count
data of 934 healthy Japanese subjects were obtained from the
JSNP database [36]. For the second stage, 980 healthy Japanese
individuals were recruited at Aichi Cancer Center Research
Institute. Genomic DNAs were extracted from peripheral blood
leukocytes with QuickGene-610L DNA extraction kit (FUJIFILM
Co., Tokyo, Japan).
Genome-wide association analysis
We designed to scan the genome in two stages. A total of 839
patients and 1,914 controls were separated into two groups; 302
cases and 934 controls for the first stage, and 537 cases and 980
controls for the second stage. In order to increase the detection
power, patients with longer axis of the eyeball (greater than
28.0 mm) were principally assigned to the first stage.
For the first stage analysis, 561,466 SNPs were genotyped in
302 patients of pathological myopia using Illumina Human-
Hap550 chips (Illumina Inc., San Diego, CA). This chip covers
approximately 87% of the common genetic variations in the
Asian population [50]. Cluster definition for each SNP was
performed using Illumina BeadStudio Genotyping Module. A
systematic quality control procedure of the genome scan results
was applied as follows. Samples were evaluated for data quality
first and markers were subsequently excluded. Genetic proximity
of sample pairs was evaluated with pi-hat in PLINK [51] and four
samples with indication of kinship or sample duplication were
excluded. Genotypes in X chromosome were used for checking
the precision of the phenotype record, and only one sample was
removed due to mismatch in gender. The final sample size of
pathological myopia was 297. As a population-based control,
genotype count data by the genome scanning of 934 healthy
Japanese subjects using the same chip were obtained from the
JSNP database [36]. The chip contained 515,154 markers in
GWAS of Pathological Myopia
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excluded 78 SNPs due to low successful call rate (,95%) in the
cases, 1,760 SNPs due to the distortion of Hardy-Weinberg
Equilibrium (HWE) in the controls (P ,10
23 by HWE exact test)
and 46,722 monomorphic SNPs. 54,817 SNPs with minor allele
frequency less than 0.05 in both cases and controls were also
excluded. After these quality control procedures, a total of
411,777 SNPs were used for the statistical analysis. The
genotyping call rate was greater than 97.43% (median call rate
99.99%) for DNA sample and 98.21% (median call rate 100%)
for SNP marker.
Association between genotypic distribution of each SNP and the
disease was examined using a x
2 test for trend. The OR and the
95% CI were estimated using Woolf’s method [52]. Inflation in
the test statistics was assessed using the genomic-control method
[37]. Haploview [53] software was used to infer the LD in the
targeted regions. SNPs with P-value adjusted by genomic control
being smaller than 10
24 were selected as candidates for second
stage. Among the candidate SNPs, LD indices (D9 and r
2) were
calculated with Haploview and when multiple SNPs were in strong
LD (D9.0.95 and r
2.0.9), one representative SNP was chosen to
be genotyped in the second stage.
In the second stage, 537 cases and 980 controls were
genotyped with the Taqman SNP assay using the ABI PRISM
7700 system (Applied Biosystems, Foster City, CA). The 302
pathological myopic cases in the first stage were also genotyped to
validate the concordance between Illumina Infinium assay and
Taqman assay. Samples with low successful call rate (,90%)
were excluded from the study. Subsequently four cases and three
controls were excluded and data of 533 cases and 977 controls
were used for the analysis. The concordance rate ranged between
98.68% and 100% for the 22 SNPs. The genotype counts of the
first and second stages were combined for meta-analysis using the
Mantel-Haenzel method [54] as a fixed-effect model. The OR
heterogeneity between the first stage and the second stage was
evaluated using Cochran’s Q-statistic P-value. The data from the
second stage were also evaluated for association independently
from the first stage.
Screening for BLID and LOC399959 expression
Human retina cDNAs were obtained from Takara Bio Inc.
(Kyoto, Japan). Total RNA of HeLa cells and human whole brain
were also obtained from the same manufacturer and cDNAs were
synthesized using the First-Strand cDNA Synthesis Kit (GE
Healthcare Life Sciences, Piscataway, NJ). Two pairs of oligonu-
cleotides were synthesized for RT-PCR; 59-TTGGGTTCCAA-
CAAAGAACC-39 and 59-CTTTTACAGGGCCTCAGCAG-39
for BLID,a n d5 9-GGCGACATCAGACAGACAGA-39 and 59-
AGGACCAGCTGAAAGGAACA-39 for LOC399959. Expression
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was tested
for cDNA quantification using 59-GACAACAGCCTCAAGAT-
CATCA-39 and 59-GGTCCACCACTGACACGTTG-39. PCR
reactions were performed under the following condition: initial
denaturation at 96uC or 2 minutes, followed by 35 cycles (for BLID
and LOC399959) or 18 cycles (for GAPDH)a t9 6 uC for 20 seconds,
60uC for 40 seconds, and polymerization at 72uC for 40 seconds.
Supporting Information
Table S1 Summary results for the 29 SNPs significant at the P
,10
24 level after population stratification adjustment in the first
stage of the genome-wide association analysis.
Found at: doi:10.1371/journal.pgen.1000660.s001 (0.06 MB
XLS)
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